ACXP
Acurx Pharmaceuticals, Inc.
$1.36
-0.09 (-6.21%)
At close · Jul 8
Market Cap
$5.84M
Shares
4,297,738
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-04-16 | 2026-04-15 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-09 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-09-19 | 2025-09-16 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| DEF 14A | 2025-08-04 | 2025-09-16 | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-06-20 | 2025-06-17 | |
| DEF 14A | 2025-05-29 | 2025-07-17 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-03-28 | 2025-03-25 | |
| 8-K | 2025-03-18 | — | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-10 | 2025-03-06 | |
| 8-K | 2025-02-26 | 2025-02-24 | |
| 8-K | 2025-01-07 | 2025-01-06 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-08-09 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-17 | |
| 8-K | 2024-03-18 | — | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2023-11-15 | — | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-03 | 2023-11-02 | |
| 8-K | 2023-10-02 | — | |
| 8-K | 2023-08-14 | — | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-06-20 | 2023-06-15 | |
| 8-K | 2023-05-17 | 2023-05-16 | |
| 10-Q | 2023-05-12 | 2023-03-31 | |
| DEF 14A | 2023-04-27 | 2023-06-15 | |
| 8-K | 2023-03-16 | — | |
| 10-K | 2023-03-15 | 2022-12-31 | |
| 8-K | 2022-11-14 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 8-K | 2022-08-15 | — | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-07-25 | — |
Showing 1–50 of 61 filings